Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study

2008 ◽  
Vol 64 (2) ◽  
pp. 297-300 ◽  
Author(s):  
Johanna Mäenpää ◽  
Arto Leminen
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Recurrent Ovarian Cancer ◽  
Dose Finding ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma

2014 ◽  
Vol 20 (14) ◽  
pp. 3683-3691 ◽  
Author(s):  
Donald W. Northfelt ◽  
Ramesh K. Ramanathan ◽  
Peter A. Cohen ◽  
Daniel D. Von Hoff ◽  
Glen J. Weiss ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Finding ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Toll Like Receptor ◽  
Finding Study ◽  
Dose Finding Study

576 Phase I dose-finding study of the combination of alimta (pemetrexed) and paclitaxel in patients with solid tumors

2003 ◽  
Vol 1 (5) ◽  
pp. S174-S175
Author(s):  
D. Zingel ◽  
C. Bolling ◽  
T. Graefe ◽  
D. Radtke ◽  
J. Latz ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Finding ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

2002 ◽  
Vol 13 (4) ◽  
pp. 546-552 ◽  
Author(s):  
M. Venturini ◽  
L. Del Mastro ◽  
O. Garrone ◽  
C. Angiolini ◽  
M. Merlano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document